Pro-cancer role of CD276 as a novel biomarker for clear cell renal cell carcinoma

CONCLUSION: CD276 expression was significantly increased in ccRCC tissues and cells and positively correlated with patient prognosis. CD276 is a potential prognostic biomarker of ccRCC. Overall, this study provides a potential therapeutic strategy for ccRCC.PMID:38600002 | DOI:10.1016/j.urolonc.2024.03.018

Source: Cancer Control - April 10, 2024 Category: Cancer & Oncology Authors: Zhi-Yu Zhang Jian-Hao Xu Jiang-Lei Zhang Yu-Xin Lin Jun Ou-Yang Source Type: research